Insider Transactions in Q2 2023 at Capricor Therapeutics, Inc. (CAPR)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 12
2023
|
Linda Marban CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
20,749
+9.46%
|
$20,749
$1.39 P/Share
|
|
Apr 17
2023
|
Xavier Avat |
SELL
Open market or private sale
|
Direct |
14,772
-100.0%
|
$949,219,176
$64258.0 P/Share
|
|
Apr 05
2023
|
Xavier Avat |
SELL
Payment of exercise price or tax liability
|
Direct |
70,019
-82.58%
|
$280,076
$4.19 P/Share
|
|
Apr 05
2023
|
Xavier Avat |
BUY
Exercise of conversion of derivative security
|
Direct |
84,791
+50.0%
|
$254,373
$3.46 P/Share
|